Introduction

A wide variety of medical conditions are treated with implantable medical devices such as coronary stents, artificial heart valves, total joint replacements, fracture plates, pedicle screws, and soft tissue anchors. These devices typically replace anatomic structures, as is the case with artificial joints, or they augment structures to enable healing of damaged tissues, as is the case with fracture fixation. Development of these devices initially focussed on structural performance, however, in certain cases, as with orthopedic devices, clinical performance relies on integration of the implant into the host bone tissue as well. For example, long-term clinical success of cementless hip implants requires implant stability (Ref 1) which is achieved by the adhesive bonds formed between the bone tissue and the surface of the hip implant (Ref 2). Recognizing the importance of implant-tissue interaction to clinical performance of implants led to the development of implant coatings. In orthopedics, implant coatings are typically applied to improve integration of the coating through adhesive bonding with bone tissue, known as osseointegration (Ref 2, 3). In developing these coatings, the ability to rapidly form strong adhesive bonds with bone tissue is a main concern in providing stability, while mechanical integrity is equally as important for clinical success.

Although implant coatings have been in use for decades, new and enhanced implant coatings are continuously being developed with a focus on improving mechanical properties and biological behaviour. These coatings with bioactive surface and adequate mechanical strength may be produced by a variety of technologies, two of which include plasma spray and sintering. The purpose of this review is to discuss recent trends (2011 to 2015) in newly developed plasma-sprayed and sintered coatings for implant applications. While implant coatings have also been developed to elute specific drugs or growth factors into the surrounding tissues, such applications are beyond the scope of this review. With implant adhesion being a main concern in developing implant coatings, a brief introduction to implant adhesion is provided.

Introduction to Implant Adhesion

Bone tissue consists of two phases: an organic collagen-rich osteoid phase synthesized by osteoblast cells, and a mineral phase of calcium-deficient carbonated apatite (Ref 2) with similar composition to hydroxyapatite (HA: Ca10(PO4)6(OH)2). Upon insertion of an implant, new bone formation occurs by osteoid synthesis and mineralization, and adhesion is achieved by mechanical interlock with surface pores and/or chemical bonding with the implant surface.

Implant surfaces may be classified as osseoinductive, which promote osseogenesis (the formation of bone) and thereby form a chemical bond to bone; or osseoconductive, which simply allow the growth of bone over the surface and typically achieve stable fixation through mechanical interlock of tissue with surface porosity or roughness. Bone-to-implant adhesion is affected by many factors such as relative movement between the implant and bone, surface roughness or porosity, and surface chemistry. Table 1 explains how bone ingrowth is affected by relative motion between the implant and bone, where motion greater than 40 µm results in loose implant fixation. For porous bioinert implant surfaces which require mechanical interlock, direct bone ingrowth can occur when pore sizes are at least 75 µm, but ideally greater than 100 µm, which allows penetration of blood vessels to maintain the living bone tissue (Ref 4). While fibrous, noncalcified tissue may form in smaller pores (Ref 4), fibrous tissue around an implant is associated with implant loosening (Ref 5). See Oliveira et al. (Ref 6) for a review of the influence of surface porosity, material, and interface conditions on bone ingrowth.

Table 1 Influence of relative motions at the implant-bone interface on bone ingrowth into porous implants (Ref 7)

The surface chemistry of the implant coating also plays a significant role in implant adhesion. The surface chemistry is a main factor in determining its bioactivity, assessed by its ability to promote HA formation. The initial formation of HA is often recognized as an early predictor to bone formation. HA forming ability is assessed by immersing a component in simulated body fluid (SBF, Table 2) followed by measurement of the surface phases by x-ray diffraction (Ref 3) or x-ray photoelectron spectrometry (Ref 8).

Table 2 Simulated body fluid (SBF) with pH 7.4 at 36.5 °C which mimics blood plasma (Ref 9)

Various coating compositions have been explored to find optimal surface chemistry for HA formation. It has been shown that terminal functional groups (i.e., ligands exposed at the surface) PO4H2, COOH, CONH2, OH, and NH2 on alkanethiols have apatite forming ability, with the PO4H2 and COOH inducing the highest HA formation rate and much lower growth rates for CONH2 and OH (Ref 8). This HA forming ability of a surface is known as bioactivity and is due to the negative surface charge of PO4H2 and COOH binding Ca2+ ions which could then complex with phosphate ions to form HA. The other groups involved ion-dipole interactions or would weakly bind phosphate which seemed less favorable for HA growth. Viitala et al. (Ref 10) showed that HA nucleation begins with Ca2+ binding to negative surface charges, which is dependent on surface chemistry. However, HA growth is dependent on surface topography as well. Thus, various studies focus on modifying surface chemistry/topography to achieve desirable bioactivity of surface coatings.

Plasma Spray

Plasma spraying is the most commercially used process in applying metal or ceramic coatings to orthopedic or dental implants (Ref 11). Plasma spraying is particularly advantageous to industry because of its fast deposition rate (Ref 12). The technique involves melting a stream of powder particles in a high-temperature plasma flame as they are discharged toward the implant surface.

This section reviews recent efforts made toward developing new or enhancing existing plasma-sprayed biocoatings, particularly HA and glass ceramic coatings.

Hydroxyapatite Coatings

HA is arguably one of the most studied coatings for implant applications and is most commonly deposited using plasma spraying technique (Ref 13). HA is a calcium phosphate bioceramic with stoichiometric form Ca10(PO4)6(OH)2, similar to that of human bone mineral components (Ref 2). With its similar chemical composition, the bioceramic is widely studied because of its osseoconductive nature which functions to enhance bone-implant interaction by stimulating bone growth and osseointegration. Although studies of HA date back several decades and the coating is used commercially today, recent literature continues to have significant content relating to the development and evolvement of HA coatings. Studies have focused on improving mechanical properties, biocompatibility and bioactivity, and resistance to bacterial growth as they are critical for long-term implant applications (Ref 13-15).

The addition of silicon-containing compounds to HA coatings has been explored to enhance biocoating properties. The choice of silicon is based on its known role in the bone remodeling process and in maintaining healthy bone. Given its role, the addition of silicon is expected to help with the growth, proliferation, and differentiation of osteoblast cells for new bone formation (Ref 16, 17), ultimately increasing the bioactivity and osseointegrative nature of the implant surface. In fact, previous studies have shown that silicon-modified HA results in increased negative surface charge attributed to the van der Waals effect of the more easily polarized Si atom (Ref 18), with Si substituting for P in the PO4 3− ion (Ref 19). The increased negative surface charge would tend to promote bone growth by attracting calcium ions which then bind to phosphates in the process of bone growth (Ref 18). The fact that negatively charged surfaces and Si-HA in particular are highly conducive to bone growth has been shown empirically both in vitro (Ref 19-21) and in vivo (Ref 19, 22). Diatomaceous earth (DE) as a source of silicon has also been demonstrated to result in improved bioactivity of Si-HA relative to the use of silicon from pure silica, possibly owing to the trace amounts minority elements Na, Mg, Al, K, and Fe in DE (Ref 23, 24) allowing it to more closely mimic natural bone in terms of composition (Ref 22). For these reasons, recent literature has continued to explore the addition of silicon to HA coatings.

Karamian et al. (Ref 13) modified HA coating through the addition of zircon (ZrSiO4) to improve the biological characteristics of HA. HA/zircon nano-biocomposite coatings with 0, 5, 10, and 15 wt.% zircon were deposited onto 316L SS dental implants (Fig. 1) and immersed in SBF. The thickness of HA layer after SBF immersion increased with increasing zircon content up to a maximum of 10 wt.%. 10 wt.% zircon had the highest release of Ca2+ and PO4 3− ions leading to local supersaturation required for nucleation and growth of apatite (Ref 25). It was hypothesized that HA/zircon coatings were superior to HA alone because of the silicate ions released. While the introduction of Si through zircon proved to enhance bioactivity of HA, in a separate study the addition of SiO2 (1, 2 and 5 wt.%) had no effect on bioactivity or mechanical properties (Ref 26).

Fig. 1
figure 1

SEM micrograph of 10 wt.% zircon in HA (Reprinted from Ref 13, Copyright (2014), with permission from Elsevier)

While HA alone has been of particular interest because of its compositional similarity to natural bone, natural bone mineral is also composed of doped ions such as Sr2+ (Ref 27), Mg2+ (Ref 28), CO3 2− (Ref 29), and F (Ref 30). These ions, as in the case of Si, have important functions to the skeletal system (Ref 31, 32), therefore to improve bioactivity of HA coatings ion-doped HA coatings have been recently developed. Strontium in particular has the ability to stimulate collagenous and noncollagenous protein synthesis and block osteoclastic bone resorption without cytotoxic effect on osteoblasts (Ref 33-35). Li et al. (Ref 36) have shown that plasma-sprayed Sr-doped HA had a positive effect on proliferation of osteoblast-like cells as compared to HA alone (Fig. 2) while also maintaining HA formation.

Fig. 2
figure 2

(a) Cell culture results of HA (g) and Sr-doped HA (h) and (b) x-ray diffraction spectra post-SBF immersion (Reprinted from Ref 36, Copyright (2012), with permission of Springer)

Apart from improving bioactivity of HA, efforts to improve mechanical properties have also been a focus in enhancing HA further. Al2O3-13 vol.% TiO2 (AT13) was deposited with HA in a bilayer manner on CP-Ti dental implant material to improve wear resistance while maintaining bioactivity through HA (Fig. 3) (Ref 37). AT13 has been previously used to coat titanium implant surface and was shown to have superior wear resistance and adhesive strength (Ref 38). It has therefore been deposited with HA, to compensate for the poor mechanical properties of HA. Bilayer coating improved wear resistance and hardness as compared to HA and AT coatings applied separately. Titanium alloy Ti-24Nb-4Zr-7.9Sn has also been combined with HA to achieve ideal coating mechanical properties while maintaining bioactivity (Ref 39). Ti-24Nb-4Zr-7.9Sn in particular comes from a series of Ti alloys which have been specifically developed to have low elastic modulus while maintaining satisfactory strength. An increase in Ti alloy content (80 wt.% in a mixture of Ti alloy/HA) resulted in improved mechanical properties, while the opposite was observed for bioactivity. Singh et al. (Ref 40) combined HA and CaP in a coating, as both have given superior bioactivity in clinical trials. However, the corrosion resistance tests of HA and HA-CaP coatings in SBF showed that HA coating deposited onto 316 L stainless steel substrate has superior corrosion resistance as compared to HA-CaP composite coating. Furthermore, following the corrosion test surface morphology of HA was unchanged while those with HA-CaP lost their surface roughness, due to the corrosion process. While CaP may improve bioactivity, its poor corrosion resistance can degrade long-term success and mechanical properties of the implants. Furthermore, high levels of released ions from corrosion products of HA-CaP may cause adverse reaction to the body.

Fig. 3
figure 3

Bilayer HA and AT (Reprinted from Ref 37, Copyright (2014), with permission from Elsevier)

Recently trending among biocoating literature is the incorporation and enhancement of bacterial growth resistance, particularly through the addition of silver. Prosthetic joint infection can complicate and prolong treatment following the insertion of prosthetic joints (Ref 41). It is caused by bacteria adhering and growing on implanted joints, however may be avoided by enhancing bacterial resistance. The addition of silver imparts antibacterial properties to implants as it is able to help prevent infections. Studies have shown that Ag+ can penetrate through bacterial cell walls and can condense DNA such that it reacts with the thiol group proteins to cause cell death (Ref 42). In terms of its use with HA coatings, Roy et al. (Ref 14) found that optimum amount of silver oxide (Ag2O) was between 2 and 4 wt.% (Fig. 4) which had excellent antimicrobial property without altering the mechanical properties.

Fig. 4
figure 4

SEM micrograph of (a) 0 wt.% Ag, (b) 2 wt.% Ag, (c) 4 wt.% Ag, and (d) 6 wt.% Ag. Open arrow indicates live cell, closed arrow indicates dead cell (Reprinted with permission from Ref 14, Copyright (2012) American Chemical Society)

Fielding et al. (Ref 15) studied the incorporation of both Ag2O and SrO (strontium oxide) into HA for improved antimicrobial activity and cell material interactions, respectively. Sr is able to displace Ca2+ ions in osteoblastic calcium-mediated processes and thus stimulate bone formation by activating calcium sensing receptors (Ref 43, 44) while also inhibiting bone resorption (Ref 45). 1 wt.% SrO/2 wt.% Ag2O-HA coatings were prepared using plasma spray equipped with supersonic plasma nozzle (Ref 15). The addition of silver alone was highly effective against bacterial colonization; however, cytotoxic effects were evident as characterized by poor cellular morphology and cell death. However, through the addition of SrO these effects were offset and improved performance of cell viability was observed as compared to HA alone. The addition of dopants also enhanced bonding strength.

Alternatively, rather than modifying HA powder to enhance the HA coating, studies have also focused on treating the substrate surface prior to plasma spraying to improve coating properties. While surface chemistry is critical for the bioactivity of the implant surface, surface topography is equally important. Developed morphological heterogeneity (on a nanometer scale) and nano-sized grains impact implant-bone interactions. Previous studies have shown that the presence of nano-topographical features helps promote the initial formation of Ca and P, and later apatite or bone (Ref 46-48). The natural human extracellular matrix is a complex network made up of a collection of nano-scale structures and features and hence is stimulated and interacts with cells on a nano-scale level (Ref 49-51). For bone, the use of artificial nano-structures allows intimate interactions with the first level of bone structural hierarchy allowing repopulation and re-synthesis of a new matrix for bone. To obtain morphological heterogeneity on a nano-scale, induction heat treatment (IHT) of substrates prior to plasma spray deposition was used (Ref 52). HA was plasma-sprayed on titanium alloy substrates subjected to IHT from 20 to 1000 °C. It was shown that both morphology and grain size could be controlled based on the temperature used for IHT before spraying. For temperatures between 800 and 1000 °C, separate agglomerated particles 30 to 90 nm in size and an average grain size of 6 nm were observed. In a separate study, it was shown that heat treatment of Ti-6Al-4V substrate to 250 °C prior to plasma spraying SiO2-doped HA (1, 2 and 5 wt.%) significantly improved the mechanical properties of the coating as compared to pure HA (Ref 26). Without preheat treatment of substrates, the SiO2 had no added effect on the mechanical properties of the coating. The authors attribute this finding to the highly porous microstructure with low crystallinity in SiO2-doped HA coatings without preheat treatment.

Titania Coatings

While HA is arguably the main focus of biocoating research, titania (TiO2) has received some attention as well. As compared with TiO2, HA has lower tensile and shear strengths and, although results can vary with the raw materials and processes used, in general, its interfacial bond strength to a titanium substrate is no better than plasma-sprayed porous TiO2 coatings. Furthermore, in certain forms HA may be resorbable, whereas resorption is not a concern with TiO2. HA is primarily superior to TiO2 in its osseointegration. The osseoinductivity of the HA coating does lead to high early fixation strength but studies suggest that the long-term performance is different from plasma-sprayed porous TiO2 coatings (Ref 53-55) with one study finding that at 6 months postsurgery, 50 to 75% more bone surrounded titanium controls than the HA-coated implants (Ref 56). For these reasons, recent studies have continued to explore the use of TiO2 coatings.

In an effort to improve the mechanical properties and bioactivity of TiO2 coating, ZrO2 was added because of its mechanical strength (Ref 57) and favorable biocompatibility and osteogenic properties (Ref 58-61). 30 wt.% ZrO2/TiO2 composite coating was plasma-sprayed onto Ti plates, as shown in Fig. 5 (Ref 62). The shear bond strength was higher, and enhanced biological behaviour of human bone marrow mesenchymal stem cells was observed in ZrO2/TiO2 coatings as compared to TiO2 alone.

Fig. 5
figure 5

SEM micrograph of (a) TiO2 and (b) 30 wt.% ZrO2/TiO2 (Ref 62, by permission of Oxford University Press)

Most recently cerium oxide (CeO2)-doped TiO2 coating on commercially pure (CP)-Ti substrate was developed to enhance antibacterial property as well as microstructure (Ref 63). Ceria has been shown previously to have excellent antibacterial properties (Ref 64, 65) while having no effect on bioactivity (Ref 64). The addition of CeO2 improved corrosion resistance and antibacterial properties and had no adverse effect on osteoblast cells. The CeO2 did not significantly change the rutile structure of TiO2, and 10 wt.% CeO2 was found to have the highest activity against bacteria (Fig. 6).

Fig. 6
figure 6

Recultivated bacterial colonies on agar: S. aureus colonies are previously dissociated from (a) TiO2, (b) 5%CeO2/TiO2, (c) 10%CeO2/TiO2, (d) 20%CeO2/TiO2, and (e) CeO2 coatings after 24 h incubation (Reprinted from Ref 63, Copyright (2015), with permission of Springer)

Other Coatings

Ceramics have been widely used as biomaterials in medicine, mainly for their wear and corrosion resistance as well as biocompatibility (Ref 66, 67). Sathish et al. (Ref 68) prepared ceramic bilayer coating similar to that shown in Fig. 3. AT13 was combined in a bilayer manner with yttria-stabilized zirconia (YSZ) by plasma spraying onto a preheated (400 °C) Ti-13Nb-13Zr alloy to improve wear and corrosion. Corrosion and wear resistance were substantially improved in the bilayer coating as compared to either coating alone. Similarly, Yildiz et al. (Ref 69) applied alumina ceramic coating to 316 L stainless steel implant to improve wear and corrosion resistance in SBF, both of which were achieved. The arc current (300 versus 500 A) was found to have no effect on wear resistance and corrosion resistance but contributed to an increased surface roughness. Alumina has also been deposited on implant surface as a buffer layer between the Ti-6Al-4V implant and HA outer layer for the purpose of depositing a coating with similar coefficient of thermal expansion (CTE) as the substrate (Ref 70), in an attempt to reduce thermal stresses at the coating-substrate interface. The alumina also acts as a diffusion barrier to prevent Al and V being released into the body, both of which are associated with health risks (Ref 71, 72). A thin layer of HA is then deposited on top of the alumina by dip coating method to provide bioactivity for early mineralization. It is expected that with time HA dissolution will occur as has been previously observed (Ref 53); however, the underneath bioinert alumina coating will remain.

Plasma Spraying Parameters

In terms of plasma spraying HA, finding the most ideal parameters for coating deposition remains a challenge. Hung et al. (Ref 73) varied parameters to determine those ideal for spraying HA on titanium alloy (Ti-6Al-4V) dental implants measuring 4.5 mm in diameter. The range of current for typical plasma-sprayed HA coating is ~350 to 1000 A (Ref 74), which is proportional to the power. It has been shown that high-power plasma spraying can elevate flame temperature and improve particle melting as well as increase particle speed (Ref 75, 76). However, increased current or power in HA coatings leads to a decrease in degree of crystallization on HA coatings (Ref 74, 77, 78). Spraying distance has also been investigated, and it has been found that with increasing spray distance crystallization is reduced, porosity is increased, fractures are increased (Ref 78), and mechanical properties are reduced (Ref 79). Hung et al. (Ref 73) found that optimal mechanical properties were obtained at 10 cm. For rod-shaped and dental screw-shaped implants, b1 and c1 spray parameters (Fig. 7), respectively, achieved best coating in terms of thickness, crystallinity, composition, and adhesion strength.

Fig. 7
figure 7

Optimal parameters for plasma spraying HA on rod-shaped (b1) and dental screw-shaped (c1) implants (Reprinted from Ref 73, Copyright (2013), with permission from Elsevier)

Evidently, plasma spray parameters strongly affect the resulting mechanical properties. As discussed by Gross et al. (Ref 80), establishing distinct properties of plasma-sprayed HA coatings is difficult as manufacturers and suppliers all use different processing conditions leading to a high variability in mechanical properties. This variability has been reported for coatings with crystalline structure but is not present for those with amorphous phases. Using nanoindentation techniques, the hardness and elastic modulus of amorphous and crystalline phases were measured on HA coatings deposited on a collection of implants obtained from different manufacturers (Ref 80). Amorphous phase had average hardness of 1.5 ± 0.3 GPa and elastic modulus of 48 ± 6 GPa. Crystalline regions had hardness between 3 and 7 GPa, with the higher values residing with sintered crystalline HA. The lower values were found to be attributed to cracking in the coating and the presence of amorphous areas. Overall hardness varied between 1 and 8 GPa. The use of nanoindentation was proven to be useful in producing a mechanical property map as small regions are accessible.

Based on the variability in mechanical properties reported above, standard parameters for HA-based coatings have not been established. As such, Table 3 condenses some plasma spraying parameters recently used in literature when preparing HA-based coatings. They may serve as initial spraying parameters if similar coatings are to be prepared for future studies. Parameters for some glass ceramic coatings are included as well.

Table 3 Atmospheric plasma spray parameters for HA and glass ceramic coatings

Glass Coatings

In place of using HA as an implant coating, glass ceramics have also been applied. Most recently calcium-silicate (CaSiO3) ceramic glass systems have been modified to improve their chemical stability, bioactivity, and mechanical integrity. Although CaSiO3 systems have been used to enhance bioactivity (Ref 81), some limitations exist. Calcium-silicate ceramics have been found to have high dissolution rates (Ref 82), with high ionic dissolution of CaSiO3 potentially leading to high-local pH environment which can result in adverse cellular response (Ref 83, 84). Yu et al. (Ref 82) added Zn to improve chemical stability (solubility), and bioactivity of calcium-silicate ceramic coatings as zinc is known to stimulate bone formation while inhibiting osteoclastic bone resorption (Ref 85). A lack of zinc has been shown to impede the growth, development, and maintenance of bone (Ref 86, 87). Hardystonite (Ca2ZnSi2O7) was therefore plasma-sprayed onto Ti-6Al-4V. The added zinc enhanced cell attachment, proliferation, and differentiation as compared to CaSiO3 coatings and uncoated Ti alloy. In a rabbit femur model, the added zinc also demonstrated new bone formation in direct contact with the coating. Wang et al. (Ref 88) also explored hardystonite (Ca2ZnSi2O7) in addition to sphene (CaTiSiO5). Both powders with nano-structures were deposited by plasma spray on Ti-6Al-4V discs. Both had bonding strength greater than that reported for HA. Primary human osteoblasts attached, spread, and proliferated well on both types of coatings because of the Ca and Si ions released. The addition of controlled release of Ca and Si ions has been shown to enhance osteoblast attachment, proliferation, and differentiation (Ref 84, 89, 90). Cell attachment and proliferation however were higher for hardystonite coatings as a result on Zn ions. The addition of ZnO and TiO2 into the CaSiO3 system also resulted in better chemical stability and reduced difference in CTE between coating and substrate. Matching coating-substrate CTE is important in avoiding high thermal stresses at the coating-substrate interface.

The addition of magnesium to CaSiO3 system has also been developed to enhance chemical stability (Ref 91). Merwinite, a tricalcium magnesium silicate powder (Ca3Mg(SiO4)2), deposited on magnesium alloy has been shown to enhance chemical stability and increase bioactivity (Ref 92, 93). Ca3Mg(SiO4)2 was therefore deposited on Ti-6Al-4V alloys using plasma spray technique. Chemical stability as well as distribution and proliferation of cells was improved as compared to the bare counterparts. Also the CTE of Ca3Mg(SiO4)2 (9.87 × 10−6/ °C) is close to that of Ti-6Al-4V (9.80 × 10−6/ °C) (Ref 94) as compared to HA (11.5 × 10−6/ °C) (Ref 95). Bredigite coating, another CaSiO3 coating infiltrated with Mg (Ca7MgSi4O16), was prepared on Ti-6Al-4V substrate using plasma spraying technique (Ref 96). Bonding strength reached 49.8 MPa, significantly higher than HA and other silicate-based bioceramics prepared by atmospheric plasma spray (APS). A distinct apatite layer was observed following SBF immersion and enhanced attachment and proliferation of rabbit bone marrow stem cells was observed as compared to HA. The authors suggest that the released SiO4 4− and Mg2+ ions and the formed nano-apatite layers are what contributed to cell proliferation.

Another variation of the calcium-silicate system, namely P2O5-Na2O-CaO-SiO2, has been shown to synthesize nano-structured coatings through liquid plasma spraying process, where a suspension is used as the feedstock (Ref 97). Quick formation of nano-structured hydroxyl carbonate apatite (HCA) layer following SBF immersion was observed. The authors use the formation of HCA as an indicator for bioactivity as its formation speed has been associated with early bone ingrowth rate and new bone formation (Ref 98).

Alternatives to Atmospheric Plasma Spray (APS)

Alternative plasma spray technologies may provide enhanced structural morphologies and compositions to enhance coatings, HA in particular. The high-temperature plasma jet in APS induces undesirable phase changes of HA resulting in powder decomposition and formation of a mixture of amorphous calcium phosphate (ACP), tricalcium phosphate (TCP), tetracalcium phosphate (TTCP), calcium oxide (CaO), and dihydroxylation products (Ref 99). CaO is particularly harmful as a hydration reaction occurs during storage or after implantation in vivo where CaO transforms into Ca(OH)2 with a 50% volume increase, resulting in internal strains and cracks (Ref 100). Furthermore, phases such as TTCP or CaO do not have any proven bioactivity and dissolve faster than other calcium phosphate phases. Dissolution rates of other phases formed during spraying follow the order ACP ≫ TTCP ≫ α-TCP ≫ OHA ≫ β-TCP ≫ HA (Fig. 8) (Ref 101, 102). While partial dissolution of HA coating is necessary for biological bonding, excessive dissolution can result in implant loosening as a result of excessive coating disintegration (Ref 53). For example, while HA can maintain its phase stability up to 1200 °C, it will transform into TCP at higher temperatures which is highly soluble in the body environment and can result in decreased implant stability (Ref 103). Optimum phase of HA is still debated as crystalline HA has been shown to be crucial for in vivo stability (Ref 104, 105) while soluble amorphous calcium phosphate (ACP), ATP, TTCP has found to accelerate bone attachment rate but may also be detrimental if excessive (Ref 106).

Fig. 8
figure 8

Calcium phosphate phases in HA coatings (Ref 53, Copyright © 2001 by John Wiley Sons, Inc. Reprinted by permission of John Wiley & Sons, Inc.)

To eradicate issues surrounding high-temperature plasma, microplasma spraying (MPS) may be used in place of conventional plasma spraying to enhance HA coatings. MPS is characterized by low plasma power (1 to 4 kW), low plasma gas flow rate, and low heat input into the substrate (Ref 107). MPS is particularly useful for the application of coatings on small parts or with high accuracy because of its smaller spray spots (3 to 5 mm) due to its narrow laminar plasma jet. These properties are very advantageous for the application of HA coatings as the temperature of the plasma jet is considerably lower than conventional plasma spraying. It generally avoids formation of impure amorphous phases, provides a higher degree of purity and crystallinity and a higher degree of porosity to facilitate bone ingrowth (Ref 107). MPS has been shown to achieve ~92% crystalline HA coatings (Ref 108) while APS is between 65 and 80% (Ref 109, 110). Furthermore, low thermal input of MPS allows 250 µm thickness with 20% porosity without affecting material properties (Ref 106). APS HA is limited to ~150 µm thickness due to accumulation of residual stress (Ref 111) and are highly dense (2 to 10% porosity). Though APS is still primarily used, experimentation with MPS is visible among the literature.

Dey et al. (Ref 112) have used MPS to evaluate HA and β-TCP-coated 316L SS pin for intra-medullary bone repair in a rabbit model. Performance of MPS β-TCP-coated pins was better than HA coated and uncoated pins in terms of new bone formation and apposition. Also the bone defect healing was better presumably due to better bone bonding and osseointegration in β-TCP-coated pins. MPS has also been used to deposit HA on 316L SS strips where 200 µm thickness and 11 vol.% porosity was attained (Ref 113). Microcracks were observed likely due to thermal shock or mismatch in CTE. Toughness value of 0.59 MPa m1/2 at 100 mN load was found, higher than that reported for APS HA (Table 4). An SBF immersion study was also conducted on the samples where needle-like nano-structured apatite was observed on the surface after 4 to 14 days immersion (Ref 107).

Table 4 Toughness of HA prepared by APS and MPS (Ref 108, 114)

Similarly, low-energy plasma spray (LEPS), an experimental low-energy version of a conventional plasma spray system has been used to deposit osteoconductive coatings on small-sized bone implants (Ref 99). Use of conventional APS to coat small implants (e.g., dental implants) produces irregular nonoptimal coatings, with concerns of failure due to microbiological susceptibility, resorption, and interfacial fracture-risk issues. Furthermore, for threaded designs, thin, controlled, and homogenous coatings are challenged by APS. This gives need for LEPS mini-gun to coat small, geometrically complex implants. Demnati et al. (Ref 115) developed a portable LEPS system for deposition of HA coatings on small-sized implants with complex geometry. Using LEPS phase purity and crystallinity of HA are better than those reported for APS without posttreatment.

Most recently, LEPS has been used to deposit HA/PCL (0.5 to 1.3 wt.%) composite coating onto Ti metallic components for femoral stem or dental implant applications (Ref 99). PCL is a polymer (poly-ε-caprolactone) with high toughness at body temperature and does not produce an acidic environment during degradation. Adding bioresorbable polymer as a second phase favors the release of residual stresses in HA coatings allowing for the production of thick coatings. Furthermore, they can encapsulate drugs for in situ drug release. To avoid degradation of the polymer, LEPS was used, with both components injected into different zones of the plasma plume. LEPS successfully deposited HA/PCL biocoatings without major PCL degradation. PCL improved layer thickness per spray pass which has economic impact, gave higher porosity with same mechanical properties as HA alone, and had higher surface roughness. Attachment and proliferation of murine osteoblast-like cells was confirmed.

While LEPS can be used to deposit polymer, Wolinne et al. (Ref 116) used a vacuum plasma spray (VPS) process to deposit metal coatings onto high- and low-temperature melting polymers including PEEK and polyethylene. VPS is performed in an Ar atmosphere at low pressure (1 to 600 mbar) with power between 5 and 30 kW. Using VPS, titanium coating was deposited on medical grade polyethylene. VPS did not cause substantial degradation but induced melting and recrystallization of polyethylene near the interface. For small displacements (<1.2 mm), coated samples were substantially stiffer, while larger displacements resulted in similar stiffness to the uncoated control (Fig. 9).

Fig. 9
figure 9

Four-point bending testing: force-displacement curves for coated (black) and uncoated (gray) samples. Two successive cycles are shown for a maximum displacement of 2.8 mm (a) and 11 mm (b). Arrows indicate the slope change occurring at ε c = 0.9% (Reprinted from Ref 116, Copyright (2014), with permission of Springer)

As opposed to MPS or LEPS, gas tunnel-type plasma spray characterized by its high-power plasma jet, successfully deposited YSZ (10, 20, and 30 wt.%)-reinforced HA coatings (Ref 117). The gas tunnel YSZ enhanced both hardness, wear resistance, and adhesive strength of the coatings while also exhibiting superior corrosion resistance as compared to HA alone. Furthermore, SBF testing showed apatite formation on all coatings except for 10 wt.% YSZ. Cytocompatibility was better than HA as confirmed by superior cell adhesion and proliferation.

The deposition of HA coatings has also been enhanced through the use of a supersonic plasma nozzle where HA particles are introduced into the plasma torch at 510 m/s, much higher than conventional plasma nozzle. In a traditional nozzle, the HA particles reside in the plasma for 5 ms, whereas in a supersonic nozzle they reside in the plasma for only 290 µs and hence have a reduced heat treatment (Ref 15). Roy et al. (Ref 118) investigated the effects of using a supersonic nozzle in depositing HA coating onto Ti. They found that using normal plasma nozzle increased phase decomposition, high ACP phase formation, and severe dihydroxylation of HA. ACP as previously mentioned, dissolves faster than its crystalline form and can therefore affect bioactive fixation (Ref 119, 120). While postdeposition heat treatment can recover crystallinity, due to volume changes from amorphous to crystalline phase transformation, large coating stresses can form resulting in disintegration or delamination (Ref 121). Furthermore, normal plasma nozzle increased phase decomposition with decreasing working distance due to prolonged plasma-HA interaction where the plasma impinges on the coating surface at close distances. This removes hydroxyl groups and enhances ACP phase formation. Those prepared with the supersonic nozzle had retained the crystallinity and phase purity of HA due to short plasma flame exposure and showed cell attachment and proliferation.

For reference, plasma spray parameters for both MPS/LEPS and supersonic plasma nozzle are given in Table 5.

Table 5 Plasma spray parameters for MPS/LEPS and supersonic nozzle

Sintered Coatings

While there is a greater emphasis on recently developed plasma-sprayed coatings for biomedical applications in the current review, newly developed HA and glass ceramic sintered coatings are also discussed for comparative reasons. Although plasma spraying is the predominant method used for coating deposition in industry, sintered bead coatings have also been used for implants and were an early form of porous ingrowth surface, introduced to cementless knee replacements in the 1980s. Typically powders or beads are applied to the implant surface either by dipping the implant or by a compaction process similar to powder metallurgy. The component is then sintered at high temperature to fuse the particles together and to the substrate (Ref 122) through a diffusion process.

Recent literature in the area of sintered biocoatings focuses on enhancing previously established coatings, such as HA and 45S5 bioglass, or in developing newly sintered biocoatings. This section reviews recent efforts made toward enhancing biocoatings prepared by sintering technique, particularly HA and glass ceramic coatings.

Hydroxyapatite Coatings

One of the primary concerns in using sintering techniques to develop biocoatings is the long sintering periods at elevated temperatures which cause HA to decompose into TCP and TTCP (Ref 123). As previously explained, TCP and TTCP have high dissolution rate which is a particular risk for implant fixation and stability (Ref 106). Furthermore, high localized dissolution can disturb surrounding tissue. Changing the intrinsic microstructure of HA has been shown to prevent decomposition during sintering (Ref 124-126). Song et al. (Ref 123) therefore prepared HA nano-rods and submicron prisms, compressed them into discs or cubes, and sintered them without pressure at 1150 to 1250 °C for 2 h. Ambient atmosphere with heating rate of 10 °C/min was used, and after samples were furnace cooled to minimize internal cracks, the HA nano-rods and submicron prisms showed no decomposition up to 1250 °C sintering temperature.

Another way to eradicate HA decomposition is to reduce sintering temperature or time. Ohtsu et al. (Ref 127) suggest a chemical coating process using slurry reagent and low-temperature sintering to obtain a thin HA coating on Ti substrate. CP-Ti powder was mixed with water and substrates were buried in the slurry then heated to 650 °C in air for 2 h. The substrates were then removed from the slurry, ultrasonically cleaned, and dried in air at 60 °C. A composite HA/TiO2 coating was fabricated (microstructure shown in Fig. 10). When heated, solid-to-solid diffusion of Ca and P from the slurry into the Ti substrate was promoted resulting in the growth of the coating. Growth rate of calcium phosphate precipitate from SBF was significantly enhanced as compared to the bare control. The newly formed coating maintained cell adhesion and proliferation, and differentiation of osteoblasts into osteocytes was enhanced (Ref 128). In a later study, Ohtsu et al. (Ref 129) varied the sintering temperature from 450 to 750 °C to find ideal temperature for biocompatibility and mechanical strength. Calcium phosphate precipitated on the surface regardless of sintering temperature; however, bond strength was highest at 625 °C.

Fig. 10
figure 10

SEM micrograph of Ti surface treated by calcium phosphate slurry at (a) 500 °C, (b) 625 °C, and (c) 750 °C (Reprinted from Ref 129, Copyright (2014), with permission from Elsevier)

The brittle nature of HA has been another focus in terms of enhancement. Previously, efforts to enhance the brittle nature of HA were made through the addition of ZrO2 where the biocompatibility of HA and the strength of ZrO2 were leveraged for orthopedic applications (Ref 130, 131). Despite their combination, HA still decomposed during sintering into β-TCP and CaO. CaO is particularly undesirable because of its tendency to undergo a hydration reaction during storage or after implantation, dangerously increasing in volume by 50% (Ref 100). Furthermore, phase transformation of partially stabilized ZrO2 from tetragonal to cubic structure occurred, diminishing the mechanical properties of the composites due to the formation of CaZrO3. Pardun et al. (Ref 132, 133) reported similar findings in terms of decomposition when the composition was predominantly HA (Fig. 11); however, reasonable mechanical strength, interfacial bonding, and bioactivity were achieved for YSZ/HA coatings with ratios of 1:1 and 2:1.

Fig. 11
figure 11

Dissolution behaviour of pure HA (CP) and YSZ-HA at varying YSZ:HA ratios (Reprinted from Ref 132, Copyright (2015), with permission from Elsevier)

Recently, Wang et al. (Ref 134) attempted to rectify these issues through the addition of TiO2 into HA/ZrO2 composite. 0 to 2.4 wt.% of TiO2 was added to HA/ZrO2 nano-powder; compacts were created; and green bodies were sintered between 900 and 1200 °C for 2 h. The addition of TiO2 restrained HA decomposition and CaZrO2 formation. As the temperature increased from 900 to 1200 °C with <0.8 wt.% TiO2, main phases found were HA and ZrO2. Above 1200 °C with > 0.8 wt.%, main phases were HA, ZrO2, and a small amount of dicalcium phosphate.

The thickness and density of HA scaffolds offer superior osseointegrative function. Sultana et al. (Ref 135) therefore propose a coating-substrate cosintering process to obtain scaffold-like HA coatings on zirconia with thicknesses between 30 and 300 µm. The microporous zirconia substrate is first prepared by presintering at 900 °C for 2 h with PMMA as sacrificial pore material, then graded HA coatings are applied, and both are cosintered at 1300 °C for 2 h. Cosintering allows a strong ceramic bond between HA and zirconia due to the densification process and chemical reactions between the interface. To account for CTE differences between HA and ZrO2, Al2O3 is added and compositions are varied with the substrate being 30 vol.% HA 70 vol.% YSZ. The first layer of the coating was 80 vol.% HA, 10 vol.% ZrO2, and 10 vol.% Al2O3 while the outside layer was 50 vol.% HA, 40 vol.% micro HA, and 10 vol.% Al2O3. Microporous HA coating with 300 µm thickness was successfully deposited on zirconia (Fig. 12). Strong adhesion was confirmed through observation/testing, and bending strength was over 300 MPa.

Fig. 12
figure 12

SEM micrograph of (a) surface morphology HA coating, (b) large pores from PMMA particles, (c) HA coating cross section, and (d) osteoblast growth after 3 days (Ref 135. Copyright © 2012 by John Wiley Sons, Inc. Reprinted by permission of John Wiley & Sons, Inc.)

The addition of ions has been another area of research as such trace elements are present in natural apatites of bone and are therefore assumed to enhance bioactivity by mimicking the composition of native bone more closely (Ref 30). Zn2+ is of particular interest as it has an important role in enzyme activity and its uptake and release are mediated by the bone reservoir in the body (Ref 136). In fact, zinc has already been shown to stimulate bone formation and mineralization (Ref 137, 138) while also having antibacterial effect (Ref 139). F ion has been shown to improve both biological properties (Ref 140) as well as mechanical properties (Ref 141). Zn2+ and F codoped HA was therefore investigated, where samples were sintered at 1100 °C for 1 h (Ref 142). Co-doping improved the mechanical properties of pure HA. The additions of Zn2+ and F enhanced the bioactivity of HA. Apart from the addition of trace elements in ionic form, 45S5 bioglass has also been combined with HA in an effort to improve bioactivity (Ref 143). According to one study, 45S5 has shown to have higher bone forming ability than HA due to surface reactions (Ref 144). The composites sintered at 1200 °C for 4 h had increased decomposition of HA to TCP which then degraded to calcium and phosphate salts and reprecipitated as an apatite layer (Ref 145). At increased 45S5 content, Na3Ca6(PO4)5 crystalline phase formed in a mixture of sodium silicate and calcium phosphate matrix which induced increased bioactivity because of their higher solubility that form HCA faster, an indicator for early bone growth rate and new bone formation (Ref 98).

Glass Ceramic Coatings

Sintering of bioactive glass is often scrutinized as the high sintering temperatures of 1000 to 1300 °C cause coating decomposition and form new undesired phases (Ref 146, 147). These high-temperature treatments can cause crystallization into glass ceramic prior to complete densification and have shown adverse effects on bioactivity (Ref 148, 149). Both composition and amorphous nature of bioactive glass control their bioactivity. Various studies have recently focused on modifying traditional 45S5 bioglass to achieve lower sintering temperatures. Bellucci et al. (Ref 150) introduce a novel bioactive glass called BioK (46.1 mol.% SiO2, 26.9 mol.% CaO, 24.4 mol.% K2O (which substituted Na2O in 45S5), and 2.6 mol.% P2O5) with reduced tendency to crystallize as compared to 45S5 bioglass (Ref 151), belonging to the same family. Through the substitution of Na2O in 45S5 by K2O, the new bioactive glass has low tendency to crystallize. 50 wt.% BioK/HA and 50 wt.% 45S5/HA green bodies were prepared. BioK/HA consolidated at a low sintering temperature of 750 °C (5 °C/min heating rate) for 3 h before crystallization phenomena could occur as compared to 1150 °C for HA/45S5. The new composite had positive effect on bioactivity evaluated by SBF immersion, superior to 45S5. The same authors investigated yet another 45S5 bioglass modified glass-HA composite with lower sintering temperature (800 °C) (Ref 152). BG_Ca is composed of 47.3 mol.% SiO2, 45.6 mol.% CaO, 4.6 mol.% Na2O, and 2.6 mol.% P2O5, which has a reduced tendency to crystallize as compared to traditional 45S5 Bioglass. Up to 80 wt.% HA-BG_Ca composites could be sintered at 800 °C as compared to 1150 °C for HA-45S5. The lower temperature preserves the amorphous nature of the glass which improved bioactivity. Furthermore reactions between glass and HA as well as HA decomposition are prevented at lower sintering temperatures. Improved vitro bioactivity and biocompatibility were obtained for 20 and 40 wt.% HA-BG_Ca composites. HA-BG_Ca showed earlier response of cell proliferation as compared to HA-45S5. Similar work was undertaken by Xie et al. (Ref 153) where 45S5 and Na2Ca2Si3O9-based bioglasses were modified to lower sintering temperature through the addition of B2O3 to ≤900 °C, while preserving bioactivity and improving mechanical properties. Figure 13(a) shows that all Na2Ca2Si3O9-based bioglasses with up to ~4 wt.% B2O3 had improved mechanical properties while maintaining HA growth as observed by XRD (Fig. 13b).

Fig. 13
figure 13

(a) Mechanical properties and (b) post-SBF immersion XRD of 45S5 and Na2Ca2Si3O9-based bioglasses (Ref 153, Fig. 5 and 7)

Kirsten et al. (Ref 154) similarly modified the composition of 45S5 bioglass to form an ideal bioactive and thermally compatible coating for zirconia dental implants through tailored substitution of alkaline earth metals and alkaline metals (Fig. 14). The demand for ceramic dental implants is increasing for esthetic reasons as compared to metal implants (Ref 155) and because patients prefer metal-free implants (Ref 156). 45S5 in its current composition is not suitable for thermal coating process on zirconia because of its high crystallization tendency and its high CTE (15 × 10−6/K) (Ref 157) as compared to zirconia (10.8 to 12.5 × 10−6/K) (Ref 158, 159). The goal is to partially replace CaO by MgO and Na2O by K2O to obtain a bioactive coating with similar CTE as zirconia. The prepared glass coatings were deposited using a spray nozzle, then were sintered at 800 °C for 100 min to obtain a dense primary layer, then were sprayed again, and sintered at 760 °C for 10 min to obtain a microstructured second layer. A coating thickness of 20 to 50 µm was achieved. CTE was well adjusted to ~0.09 × 10−6/K less than zirconia CTE. The primary layer was densely sintered without any crystallization, and no crack or delamination was found. Good bonding between the first and second layers was also found. SBF tests revealed comparable Ca/P-rich layers with similar thickness and morphology as gold standard 45S5 bioglass. In terms of cytotoxicity, the novel coating was cytocompatible having no harm to cells as determined by proliferation test of seeded mouse fibroblasts.

Fig. 14
figure 14

Glass ceramics studied by Kirsten et al. (Ref 154, copyright © 2015 by SAGE Publications, Inc. Reprinted by Permission of SAGE Publications, Inc.)

Lee et al. (Ref 160) have adjusted 45S5 bioactive glass to form BGS-7 and compared it to HA coatings. The chemical composition of BGS-7 is CaO 41.8, SiO2 35.8, P2O5 13.9, B2O3 0.5, CaF2 2.0, and MgO 6.0 (wt.%). S-pins, widely used in orthopedic surgery for fracture treatment or reconstructive surgery after osteotomy, were dip-coated using prepared slurries of BGS-7 and HA then sintered at ~875 and 500 °C for 1 h, respectively. Coating thicknesses were ~30 µm and ~550 nm for BGS-7 and HA, respectively. At all test points, BGS-7 bone-implant contact ratio following implantation in a rabbit model was higher than HA. The ultimate tensile strength of BGS-7 was higher than HA at all time points as well. Following this study, the same authors proceeded to look at different bioactive ceramic compositions (mol.%) (Fig. 15) and found that CPP and BGS-7 coated on cancellous screws inserted into tibia and femur of canine were most successful at directly bonding to cancellous bone than uncoated screws (Ref 161). Coating slurries were used and were sintered at 750 to 850 °C in a vacuum atmosphere.

Fig. 15
figure 15

Chemical composition and abbreviation of each group (Reprinted from Ref 161, Copyright (2011), with permission of Springer)

Apart from 45S5 bioglass system, calcium-silicate glass ceramic systems have also shown promise as biocoatings but are limited due to their high dissolution rate (Ref 82). To eradicate the high dissolution of CaSiO3 ceramic coatings, CaSiO3/polymer composites were fabricated (Ref 162). CaSiO3 can be fabricated by sintering compacted powders without pressure, in air at 1100 °C for 3 h at a heating rate of 2 °C/min, then cooling the samples at room temperature. Following preparation of CaSiO3, the pucks were dipped in PLGA (polylactic-co-glycolic acid) polymer solution and dried at 60 °C for 1 day. PLGA is widely used for biomedical applications (Ref 163, 164). Through the addition of the modified polymer layer, the degradation of the calcium-silicate was reduced while maintaining the apatite forming ability of the ceramic.

Baino et al. (Ref 165) aimed to develop glass ceramic coating by sintering technique with adequate adhesion using new airbrush spray method. Prepared SCNA (57SiO2-34CaO-6Na2O-3Al2O3, wt.%) slurries with different compositions (Fig. 16) were deposited onto alumina substrates using airbrush spray gun at 3.5 × 105 Pa for 2 s and then the green layers were dried for 1 h. The coatings were then sintered at 1000 °C for 3 h at a heating rate of 5 °C/min and cooling rate of 10 °C/min. The adhesion was approximately 30 MPa which is more than double the ASTM threshold for bioceramic coatings. The authors also propose a model for the newly developed airbrush spraying method in combination with sintering. The number of spraying cycles (N) required to achieve coating thickness (t) can be determined by t = CN, where C is the model constant determined by the authors (Fig. 17).

Fig. 16
figure 16

SCNA slurries deposited by airbrush spray then sintered (Reprinted from Ref 165, Copyright (2015), with permission from Elsevier)

Fig. 17
figure 17

Airbrush spraying model parameter (C) for desired coating thickness (Reprinted from Ref 165, Copyright (2015), with permission from Elsevier)

Development of new glass ceramic coatings has also been driven by antimicrobial property. Calcium-strontium-zinc-silicate glasses coupled with ionic substitution have been shown to release controlled amounts of Zn2+ and Sr2+ ions when placed in physiological conditions. The level of the ion release correlates well with the levels typically associated with clinical benefits (Ref 166, 167). Furthermore, antibacterial properties, cell viability, and osseointegration are enhanced by these elements (Ref 166, 168). The disadvantage of these glasses is their lack in providing strength for load-bearing applications. Looney et al. (Ref 169) particularly focused on enhancing the sintering cycle to maximize the mechanical strength of three glass ceramics while also investigating antibacterial property (Fig. 18). Optimum sintering temperatures of 1000, 970, and 900 °C for BT110, BT111, and BT112, respectively, were used (Fig. 18). They were heated at 5 °C/min in helium atmosphere and held at optimum sintering temperature for 3 h and then cooled at 10 °C/min. Biaxial flexural strength ranged from 70 to 149 MPa exceeding those clinically established by HA and pure β-TCP. BT112 in particular showed inhibitory effect against three of the most common bacteria found after implantation.

Fig. 18
figure 18

Glass ceramics (mol.%) studied by Looney et al. (Ref 169, copyright © 2011 by SAGE Publications, Inc. Reprinted by Permission of SAGE Publications, Inc.)

Other antimicrobial glass coatings have also been studied, particularly those belonging to B2O3-SiO2-Na2O-ZnO and SiO2-Na2O-Al2O3-CaO-B2O3 systems (Fig. 19) (Ref 170). CTE mismatch was adjusted by changing glass compositions as well as sintering atmosphere (air or Ar). The coatings were deposited on Ti-6Al-4V (air and Ar), tantalum, niobium (Ar to avoid oxidation), and 316L SS substrates (air). Green coatings were sintered in air and Ar at 725 °C for ZnO15, 630 °C for ZnO35, and 750 °C for G3 heated at 10 °C/min. Antimicrobial properties against E. coli for ZnO15 coating were good on all substrates, but better for those sintered in Ar gas as no bubbles formed. Similar results were found for ZnO35 coatings expect on Ti-6Al-4V substrates due to poor adherence. For G3 coatings, good results were only found on 316L SS.

Fig. 19
figure 19

Glass ceramics (mol.%) studied by Tejeda et al. (Reproduced with permission from Ref 170.)

Other Coatings

While most sintered biocoatings focus on HA and glass ceramics, Mutlu (Ref 171) developed a method to simultaneously sinter Ti foams for bone replacement applications while coating the foam with a biocompatible TiN layer. TiN is of interest as it has excellent corrosion and wear resistance, is biocompatible, has good adhesion, and can be used as a hard coating on load-bearing implants (Ref 172-176). The coating was fabricated by sintering the foam in N2 atmosphere at 1200 °C. Various techniques such as PVD, ion beam deposition, plasma spraying have been used to produce TiN films; however, through this combined sinter-coating process, both cost and time are reduced. An increase in mechanical properties of coated foams was observed as compared to the control.

Sintering Temperatures

Hung et al. (Ref 177) specifically studied the sintered microstructure of calcium phosphate powders with Ca/P ratio of 1.50 as opposed to hydroxyapatite (Ca10(PO4)6(OH)2) with 1.67 ratio. When pellet samples were sintered between 600 and 1200 °C for 4 h, HA remained the major phase with some rhenanite (NaCaPO4) and minor β-TCP (β-Ca3(PO4)2). At sintering temperatures of 1300 to 1400 °C for 4 h, the HA partially transformed to α-TCP (α-Ca3(PO4)2) and TTCP (Ca4(PO4)2O). Evidently, higher temperatures cause unwanted decomposition.

Modified Sintering Technologies

New sintering technologies such as spark plasma sintering (SPS), have been developed to improve the sintering technique, particularly focusing on reducing sintering time and elevated temperatures. Conventional sintering is particularly disadvantageous because of the long sintering period at elevated temperatures which has been shown to cause HA to decompose into TCP and TTCP (Ref 123). Conventional sintering supplies heat to the sample externally, whereas SPS uses a DC current to generate heat internally and significantly reduces sintering time from hours to minutes while allowing nano-structures to be retained. SPS has been used to deposit α-TCP and β-TCP powders (Ref 178), both commonly used in clinical applications such as dentistry, maxillofacial surgery, and orthopedics. For example, Mondal et al. (Ref 178) fabricated homogenous 30, 50, and 70 vol.% CP-Ti/TCP composites. Using SPS, the samples were heated to a sintering temperature of 1200 °C at a heating rate of 192 °C/min and a constant uniaxial pressure of 50 MPa was applied to the powder. After sintering the sample was cooled below 100 °C within 12 min. The mechanical properties of the composites were similar to human cortical bone and biocompatibility was enhanced with increasing TCP vol.% as indicated by increased cell adhesion, proliferation, and in vivo bone formation. In another study, SPS was used in fabricating graphene-reinforced HA samples. Graphene was added to serve as a second-phase reinforcement for improved mechanical properties. It is also a favorable candidate because of its unique structural features, its ability to be functionalized and low risk of impurity-induced toxicity (Ref 179). The sintering was carried out in vacuum at 950 °C, 30 MPa with a 3-min processing time. Both mechanical properties and in vitro bioactivity were improved by the addition of graphene. The improvement in mechanical properties is shown below (Fig. 20), in addition to an illustration explaining how the addition of graphene impeded crack propagation (Fig. 21).

Fig. 20
figure 20

Mechanical properties of HA and HA-reduced graphite oxide (rGO) (Reproduced from Ref 179, with permission of The Royal Society of Chemistry)

Fig. 21
figure 21

Crack impedance by graphene nano-sheets in HA-rGO composites. (a-1, b-1) Termination of crack growth by graphene nano-sheets at crack tip, (a-2, b-2) Deflection of crack by graphene nano-sheets, and (a-3) Bridging of the crack by graphene nano-sheets (Reproduced from Ref 179, with permission of The Royal Society of Chemistry)

The technology has also been used in preparing zirconia/titanium composites (Ref 180). Zirconia and titanium are of interest in dental and orthopedic applications due to the integrative nature with host tissue (Ref 181-184). However, the two are yet to be combined due to limitations set by conventional sintering where both phases would react with one another and the atmospheric gas, forming unwanted side compounds which weaken the structure (Ref 185, 186). With the use of SPS fast material consolidation reduces reactivity and maintains grain size similar to starting powders. Therefore (0, 25, 50, 70, 100 wt.%) 3 Y-TZP/Ti composites were fabricated using SPS at 1350 °C, 80 MPa for 10 min at a heating rate of 100 °C/min to form dense specimens (Ref 180). It was found that these composites had highest osteoblast proliferation and differentiation at longer culture times as compared to titanium and zirconium prepared separately.

Conclusions

Biocoatings have been in use for decades now, yet the literature surrounding the topic continues to grow as new materials and processes to enhance existing biocoatings are made available. The current review focuses on new or enhanced biocoatings, particularly HA and glass ceramics, prepared by plasma spray and sintering techniques within the past 5 years.

Recently developed plasma spray and sintered coatings have focused on incorporating elements found in natural bone matrix with the objective of replicating the role of those elements in the skeletal system. Some of those elements include Si (Ref 13), Zinc (Ref 82, 88, 142), and Mg (Ref 91), which among other elements found in bone, were shown to improve HA and glass coatings. Another main area of research was on bacterial growth resistance, an important aspect in reducing the risk of prosthetic joint infection. In addition to investigating the effects of varying amounts of Ag, the addition of other dopants was shown to also improve bacterial resistance, among other properties. These dopants include CeO2 (Ref 63), Zn, and Sr (Ref 169). For both plasma-sprayed and sintered biocoatings, the efforts to reduce CTE mismatch between coatings and substrates were evident among the literature. This was generally achieved by the addition or replacement of compounds and was more prominent in glass ceramics where Zn, Ti (Ref 88), and Mg (Ref 91, 154) successfully reduced CTE mismatch. Incorporation of a buffer layer was also effective (Ref 70, 135). Various methods to reduce the sintering temperature of glass ceramics have been found over the past 5 years. Several studies have modified 45S5 to lower sintering temperature through compound substitutions such as K2O (Ref 150) and B2O3 (Ref 153). These new coatings show great promise, delivering better performance than 45S5 itself. Though HA and 45S5 Bioglass were once regarded as the golden standard in biocoatings, with time these coatings have evolved and will continue to do so as their advantages are leveraged while the disadvantages are alleviated through the addition of dopants.

Apart from the new coating materials developed within the past 5 years, processing technologies in plasma spraying and sintering have advanced. Both methods are often scrutinized due to high-temperature exposure, and for sintering over a long period of time. While APS is still traditionally used in the mainstream coating development, MPS and LEPS with low plasma power have proven to be useful in reducing the harmful effects of high temperatures and in spraying polymers. Supersonic plasma nozzles can also be used to reduce the effects of high temperatures by reducing the residence time of the powder particle in the plasma. For sintering, SPS has been equally effective at alleviating high-temperature exposure by reducing the sintering time to minutes. These technologies can be useful in avoiding undesired degradation of HA and glass ceramic coatings. While they are not the traditional methods used in practice, increased experimentation with these technologies is expected.